Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clozapine for the management of persistent catatonia.

Literature DB >> 27768562

Clozapine for the management of persistent catatonia.

Karim Tabbane¹, Soumeyya Halayem¹, Ridha Joober¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2016 PMID： 27768562 PMCID： PMC5082514 DOI： 10.1503/jpn.150352

Source DB: PubMed Journal: J Psychiatry Neurosci ISSN： 1180-4882 Impact factor: 6.186

× No keyword cloud information.

13 in total

1. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study.

Authors: G S Ungvari; H F Chiu; L Y Chow; B S Lau; W K Tang
Journal: Psychopharmacology (Berl) Date: 1999-03 Impact factor: 4.530

Review 2. Clozapine and GABA transmission in schizophrenia disease models: establishing principles to guide treatments.

Authors: William T O'Connor; Sean D O'Shea
Journal: Pharmacol Ther Date: 2015-01-10 Impact factor: 12.310

Review 3. Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response.

Authors: Federica Luchini; Pierpaolo Medda; Michela Giorgi Mariani; Mauro Mauri; Cristina Toni; Giulio Perugi
Journal: World J Psychiatry Date: 2015-06-22

4. Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index?

Authors: Serdar Murat Dursun; Jaime Eduardo Cecilio Hallak; Peter Haddad; Adrian Leahy; Anne Byrne; Paul Laurence Strickland; Ian Muir Anderson; Antonio Waldo Zuardi; John F William Deakin
Journal: J Psychopharmacol Date: 2005-07 Impact factor: 4.153

Review 5. Catatonia and its treatment.

Authors: Patricia I Rosebush; Michael F Mazurek
Journal: Schizophr Bull Date: 2009-12-07 Impact factor: 9.306

6. Electroconvulsive therapy for catatonia: treatment characteristics and outcomes in 27 patients.

Authors: Jeroen A van Waarde; Joep H A M Tuerlings; Bastiaan Verwey; Rose C van der Mast
Journal: J ECT Date: 2010-12 Impact factor: 3.635

7. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.

Authors: Thomas Paparrigopoulos; Elias Tzavellas; Panagiotis Ferentinos; Iraklis Mourikis; John Liappas
Journal: World J Biol Psychiatry Date: 2009 Impact factor: 4.132

Clozapine for the management of persistent catatonia.

1. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study.

Review 2. Clozapine and GABA transmission in schizophrenia disease models: establishing principles to guide treatments.

Review 3. Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response.

4. Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index?

Review 5. Catatonia and its treatment.

6. Electroconvulsive therapy for catatonia: treatment characteristics and outcomes in 27 patients.

7. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.

Review 8. A clinical review of the treatment of catatonia.

9. Clozapine responsive catatonia: A series of five cases.

Review 10. Neurobiological Approach of Catatonia and Treatment Perspectives.

Review 1. Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.

Review 2. Catatonia in autism spectrum disorders: A systematic review and meta-analysis.